[C:1]([S:5][S:6][CH2:7][CH2:8][NH2:9])([CH3:4])([CH3:3])[CH3:2].Br[CH2:11][C:12]([O:14][CH2:15][CH3:16])=[O:13].CCN(C(C)C)C(C)C.[C:26](OC([O-])=O)([O:28][C:29]([CH3:32])([CH3:31])[CH3:30])=[O:27]>C(Cl)Cl>[C:29]([O:28][C:26]([N:9]([CH2:8][CH2:7][S:6][S:5][C:1]([CH3:4])([CH3:3])[CH3:2])[CH2:11][C:12]([O:14][CH2:15][CH3:16])=[O:13])=[O:27])([CH3:32])([CH3:31])[CH3:30]2-(tert-Butyldisulfanyl)ethanamine (Compound 6c-A, 0.21 g, 1.26 mmol) and ethyl 2-bromoacetate (0.23 g, 1.39 mmol) were dissolved in DCM (6.0 ml), DIPEA (1.10 ml, 6.31 mmol) was added, and the mixture was stirred at room temperature for 17 hours. tert-Butyl dicarbonate (358 mg, 1.64 mmol) was added to the reaction solution, and the mixture was stirred at room temperature for 15 minutes. The reaction solution was then directly purified by column chromatography (hexane:ethyl acetate=4:1) to afford the title compound (334.8 mg, 75%).